This pilot randomized controlled trial is designed to investigate the effectiveness of chair-bound exergaming on improving physical and cognitive function in pre-frail/ frail nursing home residents
Objective To explore the effects of the chair-bound exergaming on the enjoyment of physical activity in in pre-frail/ frail nursing home residents. To evaluate the effects of the chair-bound exergaming in improving physical and cognitive function in pre-frail/ frail nursing home residents. Research plan and methodology Thirty nursing home residents will be recruited from the nursing homes. All the eligible participant will be randomly allocated to either one of the following 2 groups (i) Exergaming (intervention group), or (ii) wait list control. 1. Intervention group (exergaming group, ERG) Those allocated to the ERG will receive supervised chair-bound exercise programme for 12 weeks. 2. Control group (wait list control, CG) Those allocated to the CG will receive supervised chair-bound exercise programme for 12 weeks after post-assessment.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Enrollment
30
This intervention will last 12 weeks. Frail/ pre-frail participants will engage in supervised chair-bound exergaming.
Hiu Kwong (Tak Yue) Nursing Centre
Kowloon, Hong Kong
RECRUITINGupper extremity endurance
upper extremity endurance measured by arm curl test
Time frame: T0: baseline
upper extremity endurance
upper extremity endurance measured by arm curl test
Time frame: T1: 6 week
upper extremity endurance
upper extremity endurance measured by arm curl test
Time frame: T2: immediately (1 week) after intervention
enjoyment
enjoyment of physical activity measured by Physical Activity Enjoyment Scale (PACES)
Time frame: T0: baseline
enjoyment
enjoyment of physical activity measured by Physical Activity Enjoyment Scale (PACES)
Time frame: T1: 6 week
enjoyment
enjoyment of physical activity measured by Physical Activity Enjoyment Scale (PACES)
Time frame: T2: immediately (1 week) after intervention
upper extremity strength
upper extremity strength measured by handheld dynamometer
Time frame: T0: baseline
upper extremity strength
upper extremity strength measured by handheld dynamometer
Time frame: T1: 6 week
upper extremity strength
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
upper extremity strength measured by handheld dynamometer
Time frame: T2: immediately (1 week) after intervention
lung capacity
lung capacity measured by peak flow meter
Time frame: T0: baseline
lung capacity
lung capacity measured by peak flow meter
Time frame: T1: 6 week
lung capacity
lung capacity measured by peak flow meter
Time frame: T2: immediately (1 week) after intervention
sitting balance
sitting balance measured by sitting with opened eyes, sitting with closed eyes, sitting with shaking "no" and sitting with lifted leg
Time frame: T0: baseline
sitting balance
sitting balance measured by sitting with opened eyes, sitting with closed eyes, sitting with shaking "no" and sitting with lifted leg
Time frame: T1: 6 week
sitting balance
sitting balance measured by sitting with opened eyes, sitting with closed eyes, sitting with shaking "no" and sitting with lifted leg
Time frame: T2: immediately (1 week) after intervention
feasibility, acceptability and appropriateness of intervention
feasibility, acceptability and appropriateness of intervention measured by questionnaire
Time frame: T2: immediately (1 week) after intervention
mental health
mental health measured by Patient Health Questionnaire-4 (PHQ-4), range: 0-12; higher score indicates more psychological distress
Time frame: T0: baseline
mental health
mental health measured by Patient Health Questionnaire-4 (PHQ-4), range: 0-12; higher score indicates more psychological distress
Time frame: T1: 6 week
mental health
mental health measured by Patient Health Questionnaire-4 (PHQ-4), range: 0-12; higher score indicates more psychological distress
Time frame: T2: immediately (1 week) after intervention
cognitive function
cognitive function measured by Montreal Cognitive Assessment (MoCA), range: 0-30; lower score indicates more cognitive impairment.
Time frame: T0: baseline
cognitive function
cognitive function measured by Montreal Cognitive Assessment (MoCA), range: 0-30; lower score indicates more cognitive impairment.
Time frame: T1: 6 week
cognitive function
cognitive function measured by Montreal Cognitive Assessment (MoCA), range: 0-30; lower score indicates more cognitive impairment.
Time frame: T2: immediately (1 week) after intervention